Product
Dihydroartemisinin Piperaquine
2 clinical trials
2 indications
Indication
MalariaIndication
Sickle Cell AnemiaClinical trial
Efficacy of Artemether Lumefantrine (AL) and Dihydroartemisinin-Piperaquine (DHP) for the Treatment of Uncomplicated Plasmodium Falciparum Malaria in Siaya and Bungoma Counties, KenyaStatus: Completed, Estimated PCD: 2022-12-18
Clinical trial
Dihydroartemisinin-Piperaquine or Sulphadoxine-Pyrimethamine for the Chemoprevention of Malaria in Children With Sickle Cell Anaemia in Eastern and Southern Africa: a Double Blind Randomised Trial (CHEMCHA)Status: Completed, Estimated PCD: 2023-06-30